B.Braun Receives FDA Approval for Nutrilipid 20%

B.Braun Medical, Inc. has announced it has received FDA approval of Nutrilipid 20%, an IV fat emulsion product for parenteral nutrition therapy in adult and pediatric patients. Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated. Additional information on Nutrilipid 20% is available in the B.Braun press release.